Chief Justice of India Surya Kant formed a Judicial Infrastructure Advisory Committee to assess court infrastructure nationwide and recommend funding reforms. The panel will submit a report by August 31, with the judiciary reportedly considering seeking Rs 40,000–50,000 crore for modernization and development projects.
The Delhi High Court directed Dr Reddy’s Laboratories to stop selling or expanding its diabetes drug “Olymviq,” citing phonetic similarity with Novo Nordisk’s “Ozempic.” Justice Jyoti Singh noted such similarity in pharma crosses an unacceptable threshold, indicating prima facie trademark infringement.
